-
Science & technology
Science & technology
Novavax creates transformational vaccines that help address some of the world’s most pressing infectious diseases.
- Overview
- Our pipeline
- Matrix-M™ adjuvant
- Recombinant, protein-based nanoparticle vaccine
- Global vaccine approval/authorization map
COVID-19 UPDATESNovavax has demonstrated its ability to quickly produce viable vaccine candidates for emerging infectious diseases such as COVID-19.
-
Who we are
Who we are
We are a biotechnology company committed to help address serious infectious disease globally through the discovery, development, and delivery of innovative vaccines to patients around the world.
Build your future with usJoin other passionately curious people who are bringing innovative vaccines to the world
-
Insights
Insights
Novavax is committed to accelerating the development of new and promising vaccines by building on years of study and experience.
Terms & conditions
This website has been developed as a service of Novavax, Inc. (“Novavax”). The information in this website may become out of date over time. Nothing on this website should be construed as the giving of advice or the making of a recommendation and it should not be relied on as the basis for any decision or action. Novavax accepts no liability for the accuracy nor completeness nor use of, nor any liability to update, the information contained on this website. THESE MATERIALS ARE PROVIDED “AS IS” WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT.
This is a U.S.-based website that may link you to other websites on the Internet, including the websites for Novavax affiliates in other countries. Novavax cannot take responsibility for information found on third-party Web sites. While Novavax attempts to provide links only to third-party websites that comply with all applicable laws and regulations and Novavax’s standards, the content on these third-party websites is subject to change without notice to Novavax. Novavax accepts no liability for any information or opinion contained in any third-party website.
Nothing on this website constitutes an invitation or offer to invest or deal in the securities of Novavax. In particular, actual results and developments may be materially different from any forecast, opinion or expectation expressed on this website and the past performance of the price of securities must not be relied on as a guide to their future performance.